-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

Benzinga·11/03/2025 16:23:58
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and maintains $16 price target.